SCHEMBL16352133

SCHEMBL16352133

CC(=O)N(CCCP(C)(C)=O)OCc1cccc(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.44
HCAR2 Q8TDS4 1/20 0.42
MAOA P21397 2/20 0.42
IDO1 P14902 2/20 0.39
AGXT P21549 2/20 0.39
PARP15 Q460N3 1/20 0.39
PARP14 Q460N5 1/20 0.39
PARP10 Q53GL7 1/20 0.39
GLA P06280 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
FFAR1 O14842 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16363233 0.92 MAOB (0.43) MAOBHCAR2MAOAIDO1AGXT
SCHEMBL16364162 0.88 MAOB (0.40) MAOBHCAR2MAOAIDO1AGXT
SCHEMBL16352131 0.86 MAOB (0.39) MAOBMAOAALDH1A1SMN1; SMN2
SCHEMBL16352084 0.86 L3MBTL1 (0.45) ALDH1A1
SCHEMBL16352124 0.86 NR4A2 (0.40) AGXTMMP1MMP2MMP9MMP12
SCHEMBL16352127 0.82 CETP (0.41) MAOBMMP2MMP9FFAR4
SCHEMBL16352121 0.82 SLC1A3 (0.40) MAOBCYP1A2
SCHEMBL16352153 0.82 MAOB (0.43) MAOBHCAR2MAOAIDO1AGXT
SCHEMBL16352126 0.81 ATM (0.43) MAOBMAOAIDO1SMN1; SMN2
SCHEMBL16352132 0.80 RAB9A (0.38) MAOBPARP10CYP1A2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593136-B2 Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase THE GEORGE WASHINGTON UNIVERSITY (US) 2017-03-14 US disclosed
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378418-A1 COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE DCXR, G6PD, GRHPR MAOB 1531/4885HCAR2 2800/4885MAOA 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.